ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,923Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 890

$1.1M Total Retail Price of All Prescriptions

Rank: 36 out of 890

1,017 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,017 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

14% of this provider’s 1,017 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 15,510 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
PRAVASTATIN SODIUM 900 735 1 10
AMLODIPINE BESYLATE 853 768 2 1
HYDROCODONE-ACETAMINOPHEN 644 446 S3 3 3
LEVOTHYROXINE SODIUM 584 495 4 2
OMEPRAZOLE 572 478 5 8
LISINOPRIL 544 419 6 4
METFORMIN HCL 522 422 7 6
FUROSEMIDE 462 417 8 7
DIOVAN 329 311 9 33
GABAPENTIN 305 202 10 12
METOPROLOL SUCCINATE 290 252 11 17
HYDROCHLOROTHIAZIDE 287 227 12 9
SIMVASTATIN 263 220 13 5
ATORVASTATIN CALCIUM 260 221 14 13
POTASSIUM CHLORIDE 213 185 15 11
ATENOLOL 210 159 16 23
TAMSULOSIN HCL 207 178 17 32
WARFARIN SODIUM 197 161 18 24
MELOXICAM 195 163 19 18
METOPROLOL TARTRATE 195 172 19 15
ZOLPIDEM TARTRATE 191 157 21 19
ESCITALOPRAM OXALATE 180 132 22 51
LOSARTAN POTASSIUM 176 162 23 29
NEXIUM 171 112 24 14
PANTOPRAZOLE SODIUM 164 133 25 34
CITALOPRAM HBR 146 131 26 20
PLAVIX 141 131 27 42
ALPRAZOLAM 140 114 28 95
BENAZEPRIL HCL 130 124 29 44
CLOPIDOGREL 128 113 30 28
LANTUS 126 81 31 50
CRESTOR 123 96 32 25
GLIPIZIDE XL 121 87 33 128
FLUTICASONE PROPIONATE 121 110 33 39
DONEPEZIL HCL 120 119 35 30
SERTRALINE HCL 118 84 36 26
AMOXICILLIN 118 91 36 94
TRAMADOL HCL 116 95 38 16
CARVEDILOL 112 102 39 22
CLONIDINE HCL 111 90 40 35
AMLODIPINE BESYLATE-BENAZEPRIL 107 90 41 41
FOSINOPRIL SODIUM 103 79 42 184
MIRTAZAPINE 103 96 42 82
QUINAPRIL HCL 101 77 44 116
NAMENDA 99 99 45 36
SYNTHROID 99 89 45 53
ALLOPURINOL 96 84 47 31
KLOR-CON M20 95 94 48 72
LANTUS SOLOSTAR 93 70 49 102
RANITIDINE HCL 90 82 50 49
DIGOXIN 90 89 50 65
CYMBALTA 90 81 50 45
LEXAPRO 87 65 53 186
VESICARE 87 84 53 188
POLYETHYLENE GLYCOL 3350 86 78 55 67
GLIPIZIDE 84 65 56 62
GLIMEPIRIDE 83 63 57 27
PAROXETINE HCL 82 72 58 68
VERAPAMIL ER 81 74 59 87
ALENDRONATE SODIUM 79 69 60 38
AMITRIPTYLINE HCL 77 48 R 61 43
JANTOVEN 77 76 61 169
FLUOXETINE HCL 74 70 63 63
BYSTOLIC 73 42 64 86
MUPIROCIN 71 52 65 121
HYDRALAZINE HCL 71 71 65 100
TERAZOSIN HCL 68 67 67 142
DIOVAN HCT 68 51 67 48
TRICOR 68 59 67 98
FAMOTIDINE 66 56 70 90
LIPITOR 64 58 71 77
TRAZODONE HCL 62 52 72 40
NAPROXEN 61 46 73 84
INSULIN SYRINGE 58 48 74 99
LEVOFLOXACIN 57 51 75 107
CIPROFLOXACIN HCL 56 45 76 58
GLYBURIDE-METFORMIN HCL 56 37 R 76 115
DILTIAZEM ER 55 55 78 129
PROMETHAZINE HCL 55 27 R 78 104
CELEBREX 54 48 80 91
RAMIPRIL 53 33 81 80
GLIPIZIDE ER 53 48 81 110
ONGLYZA 53 27 81 146
GLYBURIDE 52 36 R 84 83
HUMALOG 52 34 84 214
EXFORGE 50 34 86 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.